Methylation of CpG island is not a ubiquitous mechanism for the loss of oestrogen receptor in breast cancer cells

British Journal of Cancer

Volumn 77, Issue 2, 1998, Pages 181-185

  Chen, Z ^a   Ko, A ^a   Yang, J ^a   Jordan, V C ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Breast cancer; Methylation; Oestrogen receptor

Indexed keywords

ESTROGEN RECEPTOR;

ARTICLE; CPG ISLAND; DNA FINGERPRINTING; DNA METHYLATION; HORMONE RESPONSE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TUMOR CELL LINE;

EID: 0031985111     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.31     Document Type: Article

References (28)

1. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Struhl K and Smith JA (eds) (1994) Current protocols in molecular biology. John Wiley: New York
2. Carter BS, Ewing CM, Ward WS, Treiger BF, Aalders TW, Schalken JA, Epstein JI and Isaacs WB (1990) Allelic loss of chromosomes 16q and 10q in human prostate cancer. Proc Natl Acad Sci USA 87: 8751-8755
3. Chen Z and Sager R (1995) Differential expression of human tissue factor in normal mammary epithelial cells and in carcinomas. Mol Med 1: 153-160
4. Cross SH and Bird AP (1995) CpG islands and genes. Curr Opin Genet Dev 5: 309-314
5. deConinck EC, McPherson LA and Weigel RJ (1995) Transcriptional regulation of estrogen receptor in breast carcinomas. Mol Cell Biol 15: 2191-2196
6. Ferguson AT, Lapidus RG, Baylin SB and Davidson NE (1995) Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression. Cancer Res 55: 2279-2283
7. Graff JR, Herman JG, Lapidus RG, Chopra H, Xu R, Jarrard DF, Isaacs WB, Pitha PM, Davidson NE and Baylin SB (1995) E-Cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res 55: 5195-5199
8. Herman JG, Latif F, Weng Y, Lerman MI, Zbar B, Liu S, Samid D, Duan D-S, Gnarra JR, Linehan WM and Baylin SB (1994) Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci USA 91: 9700-9704
9. Herman JG, Merlo A, Mao L, Lapidus RG, Issa J-PJ, Davidson NE, Sidransky D and Baylin SB (1995) Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 55: 4525-4530
10. Issa J-PJ, Ottaviano YL, Celano P, Hamilton SR, Davidson NE and Baylin SB (1994) Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nature Genet 7: 536-540
11. Issa J-PJ, Baylin SB and Belinsky SA (1996a) Methylation of the estrogen receptor CpG island in lung tumors is related to the specific type of carcinogen exposure. Cancer Res 56: 3655-3658
12. Issa J-PJ, Zehnbauer BA, Civin CI, Collector MI, Sharkis SJ, Davidson NE, Kaufmann SH and Baylin SB (1996b) The estrogen receptor CpG island is methylated in most hematopoietic neoplasms. Cancer Res 56: 973-977
13. Jiang SY and Jordan VC (1992) Growth regulation of estrogen receptor-negative breast cancer cells transfected with complementary DNAs for estrogen receptor. J Natl Cancer Inst 84: 580-591
14. Jordan VC (ed.) (1994) Long-term Tamoxifen Treatment for Breast Cancer. University of Wisconsin Press: Madison
15. Jordan VC (1996) Tamoxifen: a Guide for Clinicians and Patients, PRR: Huntington, NY
16. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS, Johnson BE and Skolnick MH (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science 264: 436-440
17. Kuukasjarvi T, Konone J, Helin H, Holli K and Isola J (1996) Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy. J Clin Oncol 14: 2584-2589
18. Lerner LJ and Jordan VC (1990) Development of antiestrogens and their use in breast cancer: Eighth Cain Memorial Award Lecture. Cancer Res 50: 4177-4189
19. Martienssen RA and Richards EJ (1995) DNA methylation in eukaryotes. Curr Opin Genet Dev 5: 234-242
20. Murphy CS, Pink JJ and Jordan VC (1990) Characterization of a receptor-negative, hormone-nonresponsive clone derived from a T47D human breast cancer cell line kept under estrogen-free conditions. Cancer Res 50: 7285-7292
21. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K and Carson DA (1994) Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368: 753-756
22. Ottaviano YL, Issa JP, Parl FF, Smith HS, Baylin SB and Davidson NE (1994) Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. Cancer Res 54: 2552-2555
23. Pieper RO, Patel S, Ting SA, Futscher BW and Costello JF (1996) Methylation of CpG island transcription factor binding sites is unnecessary for aberrant silencing of the human MGMT gene. J Biol Chem 271: 13916-13924
24. Pink JJ and Jordan VC (1996) Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines. Cancer Res 56: 2321-2330
25. Pink JJ, Bilimoria MM, Assikis J and Jordan VC (1996) Irreversible loss of the oestrogen receptor in T47D breast cancer cells following prolonged oestrogen deprivation. Br J Cancer 74: 1227-1236
26. Razin A and Cedar H (1994) DNA methylation and genomic imprinting. Cell 77: 473-476
27. Reis RJS and Goldstein S (1982) Variability of DNA methylation patterns during serial passage of human diploid fibroblasts. Proc Natl Acad Sci USA 79: 3949-3953
28. Safarians S, Sternlicht MD, Yamanishi DT, Love SM and Barshy SH (1996) Human breast cancer progression can be regulated by dominant trans-acting factors in somatic cell hybridization studies. Cancer Res 56: 3560-3569